Blog

Read More

WelTalks on CAR-T
Prof Domenico Russo

Read More

7 ottobre 2022 – Università di Brescia: dottorato Honoris Causa al prof. Franco Locatelli

Read More

Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients

Read More

American J Hematol – 2022 – Beelen – Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic

Read More

Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients.

Read More

Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)

Read More

Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2)

Read More

Transplant Infectious Dis – 2022 – Kotton – Cytomegalovirus in the transplant setting Where are we now and what happens

Read More

18 -11-2022: Progressi in Ematologia-Dalla chemioterapia all’uso dei nuovi farmaci target-molecolari e della immunoterapia

Read More

Il Programma della Terapia Cellulare con CAR-T – Kymriah e Yescarta- è attivo presso il ns Centro